| 52-Week High | 10.77 |
|---|---|
| Last Price | 9.15 |
| Fibonacci 61.8% | 6.91 |
| Fibonacci 50% | 5.72 |
| Fibonacci 38.2% | 4.52 |
What is the difference between obln and RSLs stock?
Apr 14, 2022 · OBLN Obalon Therapeutics — Stock Price and Discussion | Stocktwits. Obalon Therapeutics NASDAQ Updated Apr 14, 2022 7:33 PM. OBLN 1.18 0.02 (1.29%) 13,562. Key Data. 52wk Low 0.83. 52wk High 14.64.
What happened to obln?
Apr 01, 2022 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced its earnings results on Thursday, March, 11th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.11. …
What happened to obln IPO 2016?
Apr 01, 2022 · The Obalon Therapeutics Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is …
Should you buy obalon Therapeutics Inc (obalon) stock when it is oversold?
Obalon Therapeutics, a commercial-stage medical device company, focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It offers the Obalon balloon system designed to provide weight loss in obese patients. The company was founded in 2008 and is based in Carlsbad, California.
Is OBLN a good stock to buy?
Obalon Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
What happened Obalon Therapeutics?
In connection with the merger's closing, Obalon changed its name to ReShape Lifesciences Inc. and the combined company's common stock will begin trading under the ticker symbol "RSLS" on The Nasdaq Capital Market beginning on June 16, 2021.Jun 16, 2021
Who merged with OBLN?
ReShape Lifesciences Inc.SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the anticipated closing of their previously announced merger to be effective after the close of the market today, June 15, 2021.Jun 15, 2021
What is Obalon weight loss?
The Obalon weight loss system uses a new method to install a gastric balloon. It combines a dietary and behavioral modification program that will help facilitate weight loss in adults aged 22 or older.
How were Obalon Therapeutics' earnings last quarter?
Obalon Therapeutics, Inc. (NASDAQ:OBLN) released its quarterly earnings data on Thursday, March, 11th. The company reported ($0.17) earnings per sh...
When did Obalon Therapeutics' stock split? How did Obalon Therapeutics' stock split work?
Shares of Obalon Therapeutics reverse split on the morning of Thursday, July 25th 2019. The 1-10 reverse split was announced on Wednesday, July 24t...
Who are Obalon Therapeutics' key executives?
Obalon Therapeutics' management team includes the following people: Mr. Andrew P. Rasdal , CEO, Pres & Director (Age 63, Pay $160.31k) Ms. Noosh...
Who are some of Obalon Therapeutics' key competitors?
Some companies that are related to Obalon Therapeutics include Nephros (NEPH) , INVO Bioscience (INVO) , Nephros (NEPHD) , NeuroOne Medical Tec...
What other stocks do shareholders of Obalon Therapeutics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Obalon Therapeutics investors own include Inovio Pharmaceu...
When did Obalon Therapeutics IPO?
(OBLN) raised $75 million in an initial public offering on Thursday, October 6th 2016. The company issued 5,000,000 shares at a price of $14.00-$16...
What is Obalon Therapeutics' stock symbol?
Obalon Therapeutics trades on the NASDAQ under the ticker symbol "OBLN."
What is Obalon Therapeutics' stock price today?
One share of OBLN stock can currently be purchased for approximately $1.09.
How much money does Obalon Therapeutics make?
Obalon Therapeutics has a market capitalization of $10.92 million and generates $1.59 million in revenue each year.
Is Obalon Therapeutics a buy right now?
What stocks does MarketBeat like better than Obalon Therapeutics?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Obalon Therapeutics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Obalon Therapeutics stock.#N#View analyst ratings for Obalon Therapeutics or view top-rated stocks.
How were Obalon Therapeutics' earnings last quarter?
Wall Street analysts have given Obalon Therapeutics a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Obalon Therapeutics wasn't one of them.
When did Obalon Therapeutics' stock split? How did Obalon Therapeutics' stock split work?
Obalon Therapeutics, Inc. (NASDAQ:OBLN) posted its earnings results on Thursday, March, 11th. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.11. The business earned $0.06 million during the quarter.
Who are some of Obalon Therapeutics' key competitors?
Obalon Therapeutics's stock reverse split before market open on Thursday, July 25th 2019. The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 24th 2019.
What other stocks do shareholders of Obalon Therapeutics own?
Some companies that are related to Obalon Therapeutics include Repro-Med Systems (REPR), Venus Concept (VERO), AIT Therapeutics (AITB), Lyra Therapeutics (LYRA), Isoray (ISR), Assure (ARHH), LENSAR (LNSR), RenovaCare (RCAR), Nephros (NEPH), Femasys (FEMY), Pro-Dex (PDEX), Avinger (AVGR), Delcath Systems (DCTH), Hancock Jaffe Laboratories (HJLI) and Universal Media Group (UMGP).#N#View all of OBLN's competitors..
What is Obalon Therapeutics' stock symbol?
Based on aggregate information from My MarketBeat watchlists, some companies that other Obalon Therapeutics investors own include Inovio Pharmaceuticals (INO), Nabriva Therapeutics (NBRV), OPKO Health (OPK), Vaxart (VXRT), Actinium Pharmaceuticals (ATNM), Inpixon (INPX), Co-Diagnostics (CODX), NIO (NIO), Novavax (NVAX) and Onconova Therapeutics (ONTX)..
Signals & Forecast
Obalon Therapeutics trades on the NASDAQ under the ticker symbol "OBLN."
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development.
Is Obalon Therapeutics Inc stock A Buy?
On the downside, the stock finds support just below today's level from accumulated volume at $2.85. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0 may give a huge drop in the stock price.
Component Grades
Obalon Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
OBLN POWR Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
OBLN Stock Summary
Growth is the dimension where OBLN ranks best; there it ranks ahead of 72.72% of US stocks.
Latest OBLN News From Around the Web
With a market capitalization of $30,565,782, Obalon Therapeutics Inc has a greater market value than only 5% of US stocks.
Continue Researching OBLN
Below are the latest news stories about Obalon Therapeutics Inc that investors may wish to consider to help them evaluate OBLN as an investment opportunity.